Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France
Cefiderocol resistance is increasingly reported in New Delhi metallo-β-lactamase–producing Enterobacterales. Genomic and phenotypic analysis of Escherichia coli sequence type 361, a primary clone causing carbapenemase spread in France, revealed mutations leading to cefiderocol resistance. Continued...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2023-09-01
|
| Series: | Emerging Infectious Diseases |
| Subjects: | |
| Online Access: | https://wwwnc.cdc.gov/eid/article/29/9/23-0390_article |
| _version_ | 1797739382725148672 |
|---|---|
| author | Agnès B. Jousset Laura Bouabdallah Aurélien Birer Isabelle Rosinski-Chupin Jean-François Mariet Saoussen Oueslati Cécile Emeraud Delphine Girlich Philippe Glaser Thierry Naas Rémy A. Bonnin Laurent Dortet |
| author_facet | Agnès B. Jousset Laura Bouabdallah Aurélien Birer Isabelle Rosinski-Chupin Jean-François Mariet Saoussen Oueslati Cécile Emeraud Delphine Girlich Philippe Glaser Thierry Naas Rémy A. Bonnin Laurent Dortet |
| author_sort | Agnès B. Jousset |
| collection | DOAJ |
| description |
Cefiderocol resistance is increasingly reported in New Delhi metallo-β-lactamase–producing Enterobacterales. Genomic and phenotypic analysis of Escherichia coli sequence type 361, a primary clone causing carbapenemase spread in France, revealed mutations leading to cefiderocol resistance. Continued genomic surveillance of carbapenem-resistant Enterobacterales could clarify prevalence of cefiderocol-resistant E. coli in Europe.
|
| first_indexed | 2024-03-12T13:56:28Z |
| format | Article |
| id | doaj.art-028c848b97b54e6599735f7d4826d6d3 |
| institution | Directory Open Access Journal |
| issn | 1080-6040 1080-6059 |
| language | English |
| last_indexed | 2024-03-12T13:56:28Z |
| publishDate | 2023-09-01 |
| publisher | Centers for Disease Control and Prevention |
| record_format | Article |
| series | Emerging Infectious Diseases |
| spelling | doaj.art-028c848b97b54e6599735f7d4826d6d32023-08-22T11:39:05ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592023-09-012991877188110.3201/eid2909.230390Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, FranceAgnès B. JoussetLaura BouabdallahAurélien BirerIsabelle Rosinski-ChupinJean-François MarietSaoussen OueslatiCécile EmeraudDelphine GirlichPhilippe GlaserThierry NaasRémy A. BonninLaurent Dortet Cefiderocol resistance is increasingly reported in New Delhi metallo-β-lactamase–producing Enterobacterales. Genomic and phenotypic analysis of Escherichia coli sequence type 361, a primary clone causing carbapenemase spread in France, revealed mutations leading to cefiderocol resistance. Continued genomic surveillance of carbapenem-resistant Enterobacterales could clarify prevalence of cefiderocol-resistant E. coli in Europe. https://wwwnc.cdc.gov/eid/article/29/9/23-0390_articleEscherichia colibacteriaantimicrobial resistanceenteric infectionsfood safetycarbapenemase |
| spellingShingle | Agnès B. Jousset Laura Bouabdallah Aurélien Birer Isabelle Rosinski-Chupin Jean-François Mariet Saoussen Oueslati Cécile Emeraud Delphine Girlich Philippe Glaser Thierry Naas Rémy A. Bonnin Laurent Dortet Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France Emerging Infectious Diseases Escherichia coli bacteria antimicrobial resistance enteric infections food safety carbapenemase |
| title | Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France |
| title_full | Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France |
| title_fullStr | Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France |
| title_full_unstemmed | Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France |
| title_short | Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France |
| title_sort | population analysis of escherichia coli sequence type 361 and reduced cefiderocol susceptibility france |
| topic | Escherichia coli bacteria antimicrobial resistance enteric infections food safety carbapenemase |
| url | https://wwwnc.cdc.gov/eid/article/29/9/23-0390_article |
| work_keys_str_mv | AT agnesbjousset populationanalysisofescherichiacolisequencetype361andreducedcefiderocolsusceptibilityfrance AT laurabouabdallah populationanalysisofescherichiacolisequencetype361andreducedcefiderocolsusceptibilityfrance AT aurelienbirer populationanalysisofescherichiacolisequencetype361andreducedcefiderocolsusceptibilityfrance AT isabellerosinskichupin populationanalysisofescherichiacolisequencetype361andreducedcefiderocolsusceptibilityfrance AT jeanfrancoismariet populationanalysisofescherichiacolisequencetype361andreducedcefiderocolsusceptibilityfrance AT saoussenoueslati populationanalysisofescherichiacolisequencetype361andreducedcefiderocolsusceptibilityfrance AT cecileemeraud populationanalysisofescherichiacolisequencetype361andreducedcefiderocolsusceptibilityfrance AT delphinegirlich populationanalysisofescherichiacolisequencetype361andreducedcefiderocolsusceptibilityfrance AT philippeglaser populationanalysisofescherichiacolisequencetype361andreducedcefiderocolsusceptibilityfrance AT thierrynaas populationanalysisofescherichiacolisequencetype361andreducedcefiderocolsusceptibilityfrance AT remyabonnin populationanalysisofescherichiacolisequencetype361andreducedcefiderocolsusceptibilityfrance AT laurentdortet populationanalysisofescherichiacolisequencetype361andreducedcefiderocolsusceptibilityfrance |